E-LIB Suche - Ergebnisse für: Ishikawa, Toru - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Regional Differences in Clinical Presentation and Prognosis..:

Toyoda, Hidenori ; Kanneganti, Mounika ; Melendez-Torres, Jonathan...
http://livrepository.liverpool.ac.uk/3171832/3/CGH.pdf. , 2024

Link: http://livrepository.liv..

2

Effects of body composition and liver function after long-t..:

Ishikawa, Toru ; Terai, Nanako ; Igarashi, Takanori...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369653/. , 2023

Link: http://www.ncbi.nlm.nih...

3

アルキル基を導入したシッフ塩基ニッケル(II)錯体の冷結晶化に関する研究:

石川徹 ; イシカワトオル ; Ishikawa Toru
甲第1699号. , 2023

Link: https://tus.repo.nii.ac...

4

An Investigation of Popping During Radiofrequency Ablation ..:

ISHIKAWA, TORU ; HASEGAWA, IORI ; HIROSAWA, HIROSHI...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026646/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Attempt to Establish Prognostic Predictive System for Hepat..:

Hiraoka, Atsushi ; Kumada, Takashi ; Tada, Toshifumi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697750/. , 2023

Link: http://www.ncbi.nlm.nih...

6

Effect of butyrate‐producing enterobacteria on advanced hep..:

Nouso, Kazuhiro ; Shiota, Shohei ; Fujita, Rio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523959/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Comparing the impact of atezolizumab plus bevacizumab and l..:

Hatanaka, Takeshi ; Kakizaki, Satoru ; Hiraoka, Atsushi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757119/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Ex Vivo Experimental Study of the Ablation Area of Bovine L..:

ISHIKAWA, TORU ; HASEGAWA, IORI ; HIROSAWA, HIROSHI...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187999/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Comparison of Ablation Volume Between Emprint(®) and Mimapr..:

Ishikawa, Toru ; Hasegawa, Iori ; Hirosawa, Hiroshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292608/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Comparison of Ablation Volume Between Emprint® and Mimapro®..:

Ishikawa, Toru ; Hasegawa, Iori ; Hirosawa, Hiroshi...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JHC.S412642. , 2023

Link: https://www.dovepress.co..

11

The hepatocellular carcinoma modified Gustave Roussy Immune..:

Hatanaka, Takeshi ; Naganuma, Atsushi ; Hiraoka, Atsushi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972107/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Does first‐line treatment have prognostic impact for unrese..:

Hiraoka, Atsushi ; Kumada, Takashi ; Tada, Toshifumi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844603/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Comparative efficacy and safety of atezolizumab and bevaciz..:

Hatanaka, Takeshi ; Kakizaki, Satoru ; Hiraoka, Atsushi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028018/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Empirical Evidence for Concepts of Spatial Information as C..:

Nyamsuren, Enkhbold ; Top, Eric ; Xu, Haiqi...
1868-8969. , 2022

Link: https://dspace.library.u..

15

International multicenter validation of GES score for HCC r..:

Shiha, Gamal ; Soliman, Reham ; Mikhail, Nabiel...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jvh.13717. , 2022

Link: https://hal.sorbonne-uni..

1-15